Biden administration plans for legal psychedelic therapies within two years

This article from The Intercept is one of a number that report on the recently emerged Substance Abuse and Mental Health Services Administration (SAMHSA) correspondence about the likely timeline for MDMA & Psilocybin licensing in the US. They write: "A letter from the Health and Human Services Department discloses the anticipated FDA approval of MDMA and psilocybin treatments.  As twin mental health and drug misuse crises kill thousands of people per week, the potential of psychedelic-assisted therapies “must be explored,” urges a federal letter on behalf of the U.S. health secretary and shared with The Intercept.  President Joe Biden’s administration “anticipates” that regulators will approve MDMA and psilocybin within the next two years for designated breakthrough therapies for PTSD and depression, respectively. The administration is “exploring the prospect of establishing a federal task force to monitor” the emerging psychedelic treatment ecosystem, according to the letter sent by Assistant Secretary for Mental Health and Substance Use Miriam Delphin-Rittmon to Rep. Madeleine Dean, D-Pa.  The May correspondence, not shared publicly until now, is the clearest indication yet that top officials are preparing for the approval of psychedelic drugs — demonized for decades after former President Richard Nixon sought means to attack the anti-Vietnam War counterculture in the late 1960s — which was arguably unthinkable even five years ago."

For more psychedelic news and research, visit the psychedelic health professional network homepage.